Pfizer (PFE) Misses Q4 EPS by 3c; Issues Lackluster Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $29.82 -0.96%
Revenue Growth %: -4.7%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
OMID, BCML, CZNC, More
Revenue Growth %: -4.7%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.47, $0.03 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $13.6 billion versus the consensus estimate of $13.64 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.50-$2.60, versus the consensus of $2.57. Pfizer sees FY2017 revenue of $52-54 billion, versus the consensus of $54 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Elevance Health Inc. (ELV) Tops Q3 EPS by $2.29, Beats on Revenue; Offers FY EPS Guidance
- Plumas Bancorp (PLBC) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
